$SSKN
STRATA Skin Sciences, Inc. Stock $sskn

$sskn Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000114036123015429 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$7.567M	$10.60M	$36.16M
YoY Change	7.47%	17.06%	20.63%
Cost Of Revenue	$3.179M	$3.754M	$14.39M
YoY Change	9.13%	22.8%	42.13%
Gross Profit	$4.388M	$6.848M	$21.77M
YoY Change	6.3%	14.13%	9.66%
Gross Profit Margin	57.99%	64.59%	60.2%
Selling, General & Admin	$6.659M	$6.273M	$25.39M
YoY Change	6.24%	-1.15%	11.26%
% of Gross Profit	151.75%	91.6%	116.63%
Research & Development	$315.0K	$441.0K	$1.029M
YoY Change	93.25%	59.78%	-28.24%
% of Gross Profit	7.18%	6.44%	4.73%
Depreciation & Amortization	$677.0K	$3.477M	$2.400M
YoY Change	8.32%	232.09%	14.29%
% of Gross Profit	15.43%	50.77%	11.03%
Operating Expenses	$6.974M	$6.714M	$26.42M
YoY Change	8.44%	1.39%	8.93%
Operating Profit	-$2.586M	$134.0K	-$4.649M
YoY Change	12.29%	-121.54%	5.61%
Interest Expense	$286.0K	-$231.0K	$926.0K
YoY Change	43.72%	12.14%	194.9%
% of Operating Profit		-172.39%
Other Income/Expense, Net	-$249.0K		-$837.0K
YoY Change	25.13%		-148.38%
Pretax Income	-$2.835M	-$97.00K	-$5.486M
YoY Change	13.31%	-88.27%	105.31%
Income Tax	$0.00	$63.00K	$63.00K
% Of Pretax Income
Net Earnings	-$2.835M	-$160.0K	-$5.549M
YoY Change	13.31%	-81.15%	105.06%
Net Earnings / Revenue	-37.47%	-1.51%	-15.35%
Basic Earnings Per Share	-$0.08		-$0.16
Diluted Earnings Per Share	-$0.08	$0.00	-$0.16
COMMON SHARES
Basic Shares Outstanding	34.88M	34.72M	34.71M
Diluted Shares Outstanding	34.86M		34.71M

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.825M	$5.434M	$5.434M
YoY Change	-74.14%	-56.83%	-56.83%
Cash & Equivalents	$2.825M	$5.434M	$5.434M
Short-Term Investments
Other Short-Term Assets	$2.052M	$2.052M	$2.052M
YoY Change	422.14%	344.16%	344.16%
Inventory	$5.695M	$5.547M	$5.547M
Prepaid Expenses
Receivables	$3.940M	$4.471M	$4.471M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$14.51M	$17.50M	$17.50M
YoY Change	-23.81%	-12.35%	-12.35%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.182M	$7.498M	$8.473M
YoY Change	18.22%	8.94%	12.66%
Goodwill	$8.803M	$8.803M
YoY Change		0.0%
Intangibles	$16.67M	$17.39M
YoY Change		72.51%
Long-Term Investments
YoY Change
Other Assets	$82.00K	$98.00K	$98.00K
YoY Change	-59.0%	-54.63%	-54.63%
Total Long-Term Assets	$34.61M	$34.77M	$34.77M
YoY Change	-3.97%	30.59%	30.59%
TOTAL ASSETS
Total Short-Term Assets	$14.51M	$17.50M	$17.50M
Total Long-Term Assets	$34.61M	$34.77M	$34.77M
Total Assets	$49.12M	$52.27M	$52.27M
YoY Change	-10.83%	12.19%	12.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.099M	$3.425M	$3.425M
YoY Change	-21.94%	21.37%	21.37%
Accrued Expenses	$6.549M	$6.555M	$6.910M
YoY Change	0.15%	2.79%	3.21%
Deferred Revenue	$2.548M	$2.778M
YoY Change	-18.36%	-15.43%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$13.06M	$13.43M	$13.43M
YoY Change	-9.44%	4.87%	4.87%
LONG-TERM LIABILITIES
Long-Term Debt	$7.517M	$7.476M	$7.476M
YoY Change	2.19%	2.15%	2.15%
Other Long-Term Liabilities	$8.921M	$9.233M	$9.233M
YoY Change	-3.72%	1065.78%	1065.78%
Total Long-Term Liabilities	$7.517M	$7.476M	$16.71M
YoY Change	-54.78%	2.15%	106.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.06M	$13.43M	$13.43M
Total Long-Term Liabilities	$7.517M	$7.476M	$16.71M
Total Liabilities	$29.80M	$30.44M	$30.44M
YoY Change	-4.81%	43.73%	43.73%
SHAREHOLDERS EQUITY
Retained Earnings	-$230.1M	-$227.2M
YoY Change		2.5%
Common Stock	$35.00K	$35.00K
YoY Change		2.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$19.32M	$21.83M	$21.83M
YoY Change
Total Liabilities & Shareholders Equity	$49.12M	$52.27M	$52.27M
YoY Change	-10.83%	12.19%	12.19%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$2.835M	-$160.0K	-$5.549M
YoY Change	13.31%	-81.15%	105.06%
Depreciation, Depletion And Amortization	$677.0K	$3.477M	$2.400M
YoY Change	8.32%	232.09%	14.29%
Cash From Operating Activities	-$1.203M	-$5.000K	-$1.108M
YoY Change	240.79%	-100.75%	-173.47%
INVESTING ACTIVITIES
Capital Expenditures	$1.406M	$1.515M	$3.552M
YoY Change	-307.07%	-234.07%	-2.76%
Acquisitions	$0.00		$631.0K
YoY Change	-100.0%		-81.83%
Other Investing Activities	$0.00	$0.00	-$631.0K
YoY Change	-100.0%		-81.83%
Cash From Investing Activities	-$1.406M	-$1.515M	-$4.183M
YoY Change	7.33%	34.07%	-41.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net			$0.00
YoY Change			-100.0%
Cash From Financing Activities	0.000	-500.0K	-500.0K
YoY Change			-643.48%
NET CHANGE
Cash From Operating Activities	-1.203M	-5.000K	-1.108M
Cash From Investing Activities	-1.406M	-1.515M	-4.183M
Cash From Financing Activities	0.000	-500.0K	-500.0K
Net Change In Cash	-2.609M	-2.020M	-5.791M
YoY Change	56.89%	338.18%	4.8%
FREE CASH FLOW
Cash From Operating Activities	-$1.203M	-$5.000K	-$1.108M
Capital Expenditures	$1.406M	$1.515M	$3.552M
Free Cash Flow	-$2.609M	-$1.520M	-$4.660M
YoY Change	-900.31%	-184.49%	117.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022	sskn	Gain Loss On Forgiveness Of Debt GainLossOnForgivenessOfDebt	0
CY2021	sskn	Gain Loss On Forgiveness Of Debt GainLossOnForgivenessOfDebt	2029000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5549000
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	8000000
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	133000
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	7275000
CY2022	sskn	Warrants Issued WarrantsIssued	0
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001051514
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	0-11635
CY2022	dei	Entity Registrant Name EntityRegistrantName	STRATA SKIN SCIENCES, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	13-3986004
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	5 Walnut Grove Drive
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 140
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Horsham
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19044
CY2022	dei	City Area Code CityAreaCode	215
CY2022	dei	Local Phone Number LocalPhoneNumber	619-3200
CY2022	dei	Security12b Title Security12bTitle	Common Stock, $0.001 Par Value
CY2022	dei	Trading Symbol TradingSymbol	SSKN
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	17222777
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	34881453
CY2022	dei	Auditor Name AuditorName	Marcum LLP
CY2022	dei	Auditor Location AuditorLocation	Philadelphia, Pennsylvania
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	585000
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	500000
CY2022	sskn	Gain Loss On Forgiveness Of Debt GainLossOnForgivenessOfDebt	0
CY2021	sskn	Gain Loss On Forgiveness Of Debt GainLossOnForgivenessOfDebt	2029000
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	500000
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	500000
CY2022	sskn	Change In Operating Lease Right Of Use Assets And Liability Due To New And Amended Lease ChangeInOperatingLeaseRightOfUseAssetsAndLiabilityDueToNewAndAmendedLease	732000
CY2021	sskn	Change In Operating Lease Right Of Use Assets And Liability Due To New And Amended Lease ChangeInOperatingLeaseRightOfUseAssetsAndLiabilityDueToNewAndAmendedLease	0
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1	71000
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1	0
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	10182000
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	0
CY2022	sskn	Noncash Or Part Noncash Acquisition Contingent Consideration Issued In Connection With Asset Acquisition NoncashOrPartNoncashAcquisitionContingentConsiderationIssuedInConnectionWithAssetAcquisition	9122000
CY2021	sskn	Noncash Or Part Noncash Acquisition Contingent Consideration Issued In Connection With Asset Acquisition NoncashOrPartNoncashAcquisitionContingentConsiderationIssuedInConnectionWithAssetAcquisition	0
CY2022	us-gaap	Stock Issued1 StockIssued1	500000
CY2021	us-gaap	Stock Issued1 StockIssued1	0
CY2022	sskn	Transfer Of Property And Equipment To Inventories TransferOfPropertyAndEquipmentToInventories	463000
CY2021	sskn	Transfer Of Property And Equipment To Inventories TransferOfPropertyAndEquipmentToInventories	0
CY2021	sskn	Warrants Issued WarrantsIssued	585000
CY2022	sskn	Assumed Deferred Revenue AssumedDeferredRevenue	0
CY2021	sskn	Assumed Deferred Revenue AssumedDeferredRevenue	1841000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5434000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12586000
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	1361000
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	0
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6795000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12586000
CY2022	us-gaap	Number Of Reporting Units NumberOfReportingUnits	2
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	79000
CY2020Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	113000
CY2022	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	246000
CY2021	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	71000
CY2022	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	118000
CY2021	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	105000
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	207000
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	79000
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	136000
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	59000
CY2022Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	71000
CY2021Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	20000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36161000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29977000
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	600000
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1300000
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	400000
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	900000
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q4	sskn	Contract With Customer Liability Current Advance Consideration ContractWithCustomerLiabilityCurrentAdvanceConsideration	400000
CY2021Q4	sskn	Contract With Customer Liability Current Advance Consideration ContractWithCustomerLiabilityCurrentAdvanceConsideration	900000
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	200000
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	400000
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	900000
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	100000
CY2021	us-gaap	Advertising Expense AdvertisingExpense	1600000
CY2022	us-gaap	Advertising Expense AdvertisingExpense	1600000
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5126344
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4402779
CY2022Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	5418000
CY2021Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	3201000
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	129000
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	288000
CY2022Q4	us-gaap	Inventory Net InventoryNet	5547000
CY2021Q4	us-gaap	Inventory Net InventoryNet	3489000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	29454000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	26654000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21956000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19771000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7498000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6883000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2400000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2100000
CY2022	sskn	Change In Operating Lease Right Of Use Assets And Liability Due To Amended Lease ChangeInOperatingLeaseRightOfUseAssetsAndLiabilityDueToAmendedLease	700000
CY2021	sskn	Change In Operating Lease Right Of Use Assets And Liability Due To Amended Lease ChangeInOperatingLeaseRightOfUseAssetsAndLiabilityDueToAmendedLease	0
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	400000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	400000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	400000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	500000
CY2022	sskn	Operating Lease Incremental Borrowing Rate Percent OperatingLeaseIncrementalBorrowingRatePercent	0.0876
CY2021	sskn	Operating Lease Incremental Borrowing Rate Percent OperatingLeaseIncrementalBorrowingRatePercent	0.0976
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M18D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	426000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	386000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	195000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	81000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1088000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	123000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	965000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	31596000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14202000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	17394000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	21414000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11331000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10083000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2900000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1600000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	3000000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2871000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2871000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2166000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1461000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1461000
CY2022Q4	us-gaap	Goodwill Goodwill	8803000
CY2021Q4	us-gaap	Goodwill Goodwill	8803000
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	136000
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	59000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1997000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2052000
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	3986000
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	3697000
CY2022Q4	sskn	Accrued Professional Fees Other Accrued Liabilities AccruedProfessionalFeesOtherAccruedLiabilities	436000
CY2021Q4	sskn	Accrued Professional Fees Other Accrued Liabilities AccruedProfessionalFeesOtherAccruedLiabilities	569000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6555000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6377000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1000000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	4000000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	8000000
CY2022Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	100000
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	300000
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	300000
CY2022	sskn	Development Agreement Term DevelopmentAgreementTerm	P3Y
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	358367
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	329076
CY2021	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	234558
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	200000
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M6D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y11M15D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.8957
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.9003
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0251
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0108
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	23000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	22000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	23000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	22000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	23000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	23000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	17000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-11000
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	40000
CY2021	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	12000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	63000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	45077000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	46596000
CY2022Q4	sskn	Deferred Tax Assets Intangible Assets DeferredTaxAssetsIntangibleAssets	1697000
CY2021Q4	sskn	Deferred Tax Assets Intangible Assets DeferredTaxAssetsIntangibleAssets	1039000
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	57000
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	26000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1431000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1230000
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1111000
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	441000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	548000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	458000
CY2022Q4	sskn	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	242000
CY2021Q4	sskn	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	159000
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	1095000
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	950000
CY2022Q4	sskn	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	240000
CY2021Q4	sskn	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	177000
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	333000
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	667000
CY2022Q4	sskn	Deferred Tax Liabilities Interest Expense Limitation Carryover DeferredTaxLiabilitiesInterestExpenseLimitationCarryover	208000
CY2021Q4	sskn	Deferred Tax Liabilities Interest Expense Limitation Carryover DeferredTaxLiabilitiesInterestExpenseLimitationCarryover	0
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	49005000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	48457000
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	306000
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	266000
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	500000
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	100000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0058
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0033
CY2022	sskn	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	-0.0223
CY2021	sskn	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	0.089
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.112
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.2527
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0814
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0557
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0115
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0127
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36161000
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1000000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	14393000
CY2022	us-gaap	Gross Profit GrossProfit	21768000
CY2022	sskn	Percentage Of Gross Profit PercentageOfGrossProfit	0.602
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1029000
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	15301000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10087000
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	26417000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-4649000
CY2022	us-gaap	Interest Expense InterestExpense	926000
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	89000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5486000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29977000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	10127000
CY2021	us-gaap	Gross Profit GrossProfit	19850000
CY2021	sskn	Percentage Of Gross Profit PercentageOfGrossProfit	0.662
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1434000
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13106000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9712000
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	24252000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-4402000
CY2021	us-gaap	Interest Expense InterestExpense	314000
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	15000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2029000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2672000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5293000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3736000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36161000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29977000
CY2022Q4	us-gaap	Assets Assets	52272000
CY2021Q4	us-gaap	Assets Assets	46593000
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	600000

Files In Submission

Name	View Source	Status
brhc10049943_10k_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
sskn-20221231_cal.xml	Edgar Link	unprocessable
0001140361-23-015429-index-headers.html	Edgar Link	pending
0001140361-23-015429-index.html	Edgar Link	pending
0001140361-23-015429.txt	Edgar Link	pending
0001140361-23-015429-xbrl.zip	Edgar Link	pending
brhc10049943_10k.htm	Edgar Link	pending
brhc10049943_ex10-25.htm	Edgar Link	pending
brhc10049943_ex23-1.htm	Edgar Link	pending
brhc10049943_ex31-1.htm	Edgar Link	pending
brhc10049943_ex31-2.htm	Edgar Link	pending
brhc10049943_ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sskn-20221231.xsd	Edgar Link	pending
sskn-20221231_def.xml	Edgar Link	unprocessable
sskn-20221231_lab.xml	Edgar Link	unprocessable
sskn-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SSKN
STRATA Skin Sciences, Inc. Stock $sskn

2023 Q1 Form 10-K Financial Statement

#000114036123015429 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSKN STRATA Skin Sciences, Inc. Stock $sskn

2023 Q1 Form 10-K Financial Statement

#000114036123015429 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSKN
STRATA Skin Sciences, Inc. Stock $sskn